Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

In international guidelines, influenza vaccination is recommended to cancer patients receiving antitumor treatment. Whether this recommendation should include patients treated with the recently introduced and now widely used checkpoint inhibitors (CPIs) is unclear. The immune hyperactivation after v...

Descripción completa

Detalles Bibliográficos
Autores principales: Valachis, Antonios, Rosén, Camilla, Koliadi, Anthoula, Digkas, Evangelos, Gustavsson, Alice, Nearchou, Andreas, Ullenhag, Gustav J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894446/
https://www.ncbi.nlm.nih.gov/pubmed/33643697
http://dx.doi.org/10.1080/2162402X.2021.1886725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894446/
https://www.ncbi.nlm.nih.gov/pubmed/33643697
http://dx.doi.org/10.1080/2162402X.2021.1886725

Ejemplares similares